Billy, last I heard was October reporting results for the...

Billy, last I heard was October reporting results for the Reach2HD trial and December completing the IMAGINE Alzheimer's trial. The HD trial should be finished by mid year, but then it is a case of how long it takes to crunch the numbers. Remember this is a blinded trial so investigators do not know who was on the drug till unblinding at trial completion.
Goins, it is just another of many studies now backing up what Prana have been saying all along about AD and PD. Metals imbalance(dyshomeostasis) plays a large role in neurodegeneration,( However, there is strong support for the involvement of metal dyshomeostasis, inflammation, and oxidative damages to biomolecules in both diseases) and that restoring the correct balance is likely to have a positive effect.
I think where Prana have it all over the chelators spoken about is that Prana's MPACs use the essential metals already trapped in the plaques, and instead of trying to get the right balance with iron chelation(removal), PBT2 instead repairs the neuron's own iron clearance mechanism, allowing the neuron to regulate the correct iron levels.